NCT07009210 AI Assisted Personalized Legacy Program (Reflections: My Story) for Patients With Serious Illness
| NCT ID | NCT07009210 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Serious Illness |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-08-11 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-08-11 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the AI Assisted Personalized Legacy Program intervention to patients with serious illness.
Eligibility Criteria
Participant population: Adults with serious illness - defined as a health condition that carries a high risk of mortality Inclusion Criteria for patients: 1. Age ≥18 years 2. English fluency 3. Provide informed consent 4. Ability to complete questionnaire(s) by themselves or with assistance Exclusion Criteria: 1. Other psychological co-morbidities such as untreated schizophrenia, bipolar disease 2. Recent suicide attempt or psychiatric illness severe enough that hospitalization has been necessary in last 6 months 3. Active delirium 4. Advanced dementia 5. Participation in concurrent legacy offerings through the palliative care clinic
Contact & Investigator
Deirdre Pachman, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic in Rochester
Frequently Asked Questions
Who can join the NCT07009210 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Serious Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07009210 currently recruiting?
Yes, NCT07009210 is actively recruiting participants. Contact the research team at felt.melissa@mayo.edu for enrollment information.
Where is the NCT07009210 trial being conducted?
This trial is being conducted at Phoenix, United States, Rochester, United States.
Who is sponsoring the NCT07009210 clinical trial?
NCT07009210 is sponsored by Mayo Clinic. The principal investigator is Deirdre Pachman, MD at Mayo Clinic in Rochester. The trial plans to enroll 20 participants.